@article{9666664458c74a5196594ca756cc5f92,
title = "The influence of safety warnings on the prescribing of JAK inhibitors",
author = "Russell, {Mark D.} and Zijing Yang and Ben Walter and Edward Alveyn and Katie Bechman and Aitana Miracle and Deepak Nagra and Adas, {Maryam A.} and Sam Norton and Cope, {Andrew P.} and Langan, {Sin{\'e}ad M.} and Galloway, {James B.}",
note = "Funding Information: No authors received funding for this Correspondence, and there was no industry involvement or oversight for any stage of this project. JBG has acted in an advisory role to many pharmaceutical companies (listed below), including to provide specific advice on safety with JAK inhibition for the purposes of regulatory review. JBG has received honoraria from AbbVie, Biovitrum, BMS, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Roche, Sanofi, Sobi, and UCB. MDR has received honoraria from AbbVie, Lilly, Galapagos, Menarini, and Viforpharma; advisory board fees from Biogen; and support for attending educational meetings from Lilly, Pfizer, Janssen, and UCB. APC has received consulting fees from AbbVie; honoraria for lectures and speakers' bureaus from AbbVie and Galapagos; and support for attending educational meetings from AbbVie. KB has received grant funding from NIHR; honoraria from UCB and Viforpharma; and educational support from UCB. All other authors declare no competing interests. All data utilised in this study can be accessed in the cited studies, and can be shared upon reasonable request. Contributions were as follows: conceptualisation: MDR, JBG, and SN; methodology: MDR, JBG, SN, SML, KB, MAA, and ZY; formal analysis: MDR, JBG, SN, EA, BW, and ZY; writing (original draft): MDR and JBG; writing (revising, review, and editing): all authors. All authors read and approved the final manuscript. MDR and JBG are the guarantors and accept full responsibility for the work and the conduct of the study, and controlled the decision to publish. MDR and JBG directly accessed and verified the underlying data reported in the manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. ",
year = "2024",
month = mar,
doi = "10.1016/S2665-9913(24)00002-X",
language = "English",
volume = "6",
pages = "e138--e139",
journal = "The Lancet Rheumatology",
issn = "2665-9913",
publisher = "Elsevier",
number = "3",
}
